Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)
Brazil
· Delayed Price · Currency is BRL 8.79
+0.08 (0.92%)
Apr 24, 2025, 2:44 PM GMT-3
BVMF:PNVL3 Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 4,942 | 4,461 | 3,990 | 3,225 | 2,819 | Upgrade
|
| Revenue Growth (YoY) | 10.79% | 11.79% | 23.72% | 14.41% | 3.47% | Upgrade
|
| Cost of Revenue | 3,364 | 3,079 | 2,745 | 2,231 | 1,988 | Upgrade
|
| Gross Profit | 1,578 | 1,382 | 1,245 | 994.64 | 831.01 | Upgrade
|
| Selling, General & Admin | 1,368 | 1,210 | 1,099 | 907.41 | 726.33 | Upgrade
|
| Other Operating Expenses | 12.91 | 9.53 | 8 | -15.56 | 11.29 | Upgrade
|
| Operating Expenses | 1,381 | 1,220 | 1,107 | 891.85 | 737.62 | Upgrade
|
| Operating Income | 197.33 | 161.89 | 137.84 | 102.78 | 93.39 | Upgrade
|
| Interest Expense | -103.97 | -102.57 | -70.03 | -37.12 | -35.31 | Upgrade
|
| Interest & Investment Income | 30.99 | 34.39 | 18.18 | 16.63 | 6.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -9.73 | -6.81 | -7.01 | 2.2 | -9.6 | Upgrade
|
| EBT Excluding Unusual Items | 114.62 | 86.9 | 78.99 | 84.49 | 54.54 | Upgrade
|
| Gain (Loss) on Sale of Assets | -4.03 | -2.26 | -2.07 | -2.74 | -1.85 | Upgrade
|
| Other Unusual Items | 1.97 | 6.95 | 1.51 | 1.49 | 0.62 | Upgrade
|
| Pretax Income | 112.56 | 91.58 | 78.43 | 83.24 | 53.3 | Upgrade
|
| Income Tax Expense | 7.06 | -1.32 | -7.92 | 3.81 | -2.85 | Upgrade
|
| Net Income | 105.51 | 92.91 | 86.35 | 79.43 | 56.15 | Upgrade
|
| Net Income to Common | 105.51 | 92.91 | 86.35 | 79.43 | 56.15 | Upgrade
|
| Net Income Growth | 13.57% | 7.60% | 8.71% | 41.45% | -26.84% | Upgrade
|
| Shares Outstanding (Basic) | 149 | 149 | 149 | 150 | 151 | Upgrade
|
| Shares Outstanding (Diluted) | 150 | 150 | 149 | 150 | 152 | Upgrade
|
| Shares Change (YoY) | 0.42% | 0.38% | -0.30% | -1.27% | 11.84% | Upgrade
|
| EPS (Basic) | 0.71 | 0.62 | 0.58 | 0.53 | 0.37 | Upgrade
|
| EPS (Diluted) | 0.70 | 0.62 | 0.58 | 0.53 | 0.37 | Upgrade
|
| EPS Growth | 12.90% | 6.90% | 9.43% | 43.02% | -34.59% | Upgrade
|
| Free Cash Flow | 101.73 | 182.2 | 56.18 | 21.13 | 67.1 | Upgrade
|
| Free Cash Flow Per Share | 0.68 | 1.22 | 0.38 | 0.14 | 0.44 | Upgrade
|
| Dividend Per Share | - | 0.252 | - | 0.175 | 0.136 | Upgrade
|
| Dividend Growth | - | - | - | 28.37% | -19.11% | Upgrade
|
| Gross Margin | 31.94% | 30.97% | 31.20% | 30.84% | 29.48% | Upgrade
|
| Operating Margin | 3.99% | 3.63% | 3.45% | 3.19% | 3.31% | Upgrade
|
| Profit Margin | 2.14% | 2.08% | 2.16% | 2.46% | 1.99% | Upgrade
|
| Free Cash Flow Margin | 2.06% | 4.08% | 1.41% | 0.66% | 2.38% | Upgrade
|
| EBITDA | 367.87 | 362.04 | 322.41 | 260.56 | 211.17 | Upgrade
|
| EBITDA Margin | 7.44% | 8.12% | 8.08% | 8.08% | 7.49% | Upgrade
|
| D&A For EBITDA | 170.54 | 200.15 | 184.57 | 157.77 | 117.78 | Upgrade
|
| EBIT | 197.33 | 161.89 | 137.84 | 102.78 | 93.39 | Upgrade
|
| EBIT Margin | 3.99% | 3.63% | 3.45% | 3.19% | 3.31% | Upgrade
|
| Effective Tax Rate | 6.27% | - | - | 4.58% | - | Upgrade
|
| Revenue as Reported | 4,942 | 4,461 | 3,990 | 3,225 | - | Upgrade
|
| Advertising Expenses | 33.16 | 29.34 | 26.21 | 19.88 | 17.54 | Upgrade
|
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.